Clinical Trial Update: Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether the HSD3B1 (1245C) gene mutation affects treatment outcomes in Stage I–III breast cancer and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Adenocarcinoma
• Breast Cancer
• Invasive Breast Carcinoma of No Special Type

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 4 | Status: RECRUITING